Celgene Corporation

CELG 
(NASDAQ) 
 
$ 88.95 <%= Resources.Global.txtDown %>
Updated 20/04/2018
Change % -0.75% Stock price decreasing
Change -0.67 Stock price decreasing
Volume 3,091,497
High $ 90.13
Low $ 88.27
Open $ 89.42
ISIN
Prev close $ 89.62
# of shares 752.18M
Market cap 66,906M USD
Intraday

Market closed
Celgene Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  88.95 -1.8% Stock price decreasing 4.7% Stock price increasing -14.9% Stock price decreasing -27.3% Stock price decreasing -27.2% Stock price decreasing
Powered by TradingView

News about Celgene Corporation

  • English
  • Regulatory news
17 Apr
 
16 Apr
 
14 Apr
 
06 Apr
 
03 Apr
 
02 Apr
 
31 Mar
 
20 Mar
 
02 Feb
 
28 Nov
 

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Shire PLC ORD 5P 3,894.50 9.4% Stock price increasing 30.7% Stock price increasing 11.0% Stock price increasing 6.0% Stock price increasing -13.4% Stock price decreasing -0.1% Stock price decreasing
 
Bristol-Myers Squibb Company 51,17 -5.4% Stock price decreasing -17.5% Stock price decreasing -19.3% Stock price decreasing -19.7% Stock price decreasing -4.3% Stock price decreasing -16.5% Stock price decreasing
 
Johnson & Johnson 126,66 -3.9% Stock price decreasing 1.2% Stock price increasing -10.7% Stock price decreasing -11.8% Stock price decreasing 4.0% Stock price increasing -9.3% Stock price decreasing
 
Merck & Company Inc (new) 58,83 2.9% Stock price increasing 10.1% Stock price increasing -4.7% Stock price decreasing -7.2% Stock price decreasing -4.9% Stock price decreasing 4.5% Stock price increasing
 
Pfizer Inc 36.63 0.3% Stock price increasing 6.2% Stock price increasing -0.5% Stock price decreasing 0.6% Stock price increasing 8.9% Stock price increasing 1.1% Stock price increasing
 
Amgen Inc 171,56 0.1% Stock price increasing 1.3% Stock price increasing -10.6% Stock price decreasing -5.0% Stock price decreasing 7.0% Stock price increasing -1.3% Stock price decreasing
 
Gilead Sciences Inc 73.70 -1.3% Stock price decreasing 1.2% Stock price increasing -9.0% Stock price decreasing -8.1% Stock price decreasing 11.8% Stock price increasing 2.9% Stock price increasing
 
Vertex Pharmaceuticals Incorpo.. 158.15 -0.3% Stock price decreasing -1.7% Stock price decreasing -5.1% Stock price decreasing 4.7% Stock price increasing 35.5% Stock price increasing 5.5% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 4,984.50 1.4% Stock price increasing 4.1% Stock price increasing -2.3% Stock price decreasing -3.0% Stock price decreasing 9.2% Stock price increasing -2.7% Stock price decreasing
 
Novartis AG 77.88 -4.1% Stock price decreasing -0.9% Stock price decreasing -10.7% Stock price decreasing -9.3% Stock price decreasing 6.1% Stock price increasing -7.2% Stock price decreasing
 
Takeda PHARM.CO.LTD. 36.71 -3.9% Stock price decreasing -12.1% Stock price decreasing -24.2% Stock price decreasing -21.4% Stock price decreasing -17.8% Stock price decreasing -21.6% Stock price decreasing
 
Biogen Inc 263,02 0.0% Stock price decreasing 1.1% Stock price increasing -24.1% Stock price decreasing -19.9% Stock price decreasing -3.6% Stock price decreasing -17.4% Stock price decreasing

Company profile

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Pending acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Peers

Instruments Last Change  
Shire PLC OR.. 3,894.50 1.9% Stock price increasing
Bristol-Myer.. 51,17 -0.9% Stock price decreasing
Johnson & Jo.. 126,66 -0.7% Stock price decreasing
Merck & Comp.. 58,83 0.3% Stock price increasing
Pfizer Inc 36.63 0.3% Stock price increasing
Amgen Inc 171,56 -0.8% Stock price decreasing
99,76,57,60,45,35,30,22,21,36
Gilead Scien.. 73.70 -1.0% Stock price decreasing
83,50,21,19,28,38,66,36,60,83
Vertex Pharm.. 158.15 -0.9% Stock price decreasing
96,54,42,76,68,51,24,4,17,43
Astrazeneca .. 4,984.50 0.2% Stock price increasing
Novartis AG 77.88 -1.4% Stock price decreasing
Takeda PHARM.. 36.71 -0.3% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Biogen Inc 263,02 -1.1% Stock price decreasing
100,51,23,55,76,74,66,46,43,32

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 April 2018 08:31:08
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180417.1 - EUROWEB5 - 2018-04-23 09:31:08 - 2018-04-23 08:31:08 - 1000 - Website: OKAY